Investor Relations

IR Overview

FluoroPharma Medical, Inc. (OTCQB: FPMI)

FluoroPharma Medical, Inc. (FPMI) engages in the discovery, development and commercialization of proprietary medical diagnostic imaging products. The company’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease (CAD).

Quick Links

FluoroPharma Investor Call Audio Archive    

Recent News


Share Statistics

Outstanding: 32,041,360
(as of November 14, 2015)

Company Information

FluoroPharma Medical, Inc.
8 Hillside Ave
Suite 108
Montclair, NJ 07042

Management Team

Thomas Tulip
CEO & President

Tamara Rhein
CFO

Investor Relations

Bob Prag
The Del Mar Consulting Group, Inc.
bprag@delmarconsulting.com
(858) 794-9500

Transfer Agent

Vstock Transfer, LLC
77 Spruce Street
Suite 201
Cedarhurst, New York 11516
(212) 828-8436

Auditors

Wolf & Company, P.C.
99 High Street
Boston, MA 02110
(617) 933-3368